Systematic review with meta-analysis: Saccharomyces boulardii for treating acute gastroenteritis in children-a 2020 update.
- 2020-02-13
- Meta-Analysis · n = 3,450
- Alimentary pharmacology & therapeutics 51(7)
- Hania Szajewska
- Maciej Kołodziej
- Bartłomiej M Zalewski
- PubMed: 32056266
- DOI: 10.1111/apt.15659
- High evidence
- Rigorous Journal
- Clinical
S boulardii use was also associated with a reduced duration of hospitalisation (8 RCTs, n = 999, mean difference -0.85 day, 95% CI -1.35 to -0.34; I2 = 91%) (very low quality of evidence).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes